NASDAQ:ZY Zymergen (ZY) Stock Price, News & Analysis Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$2.43▼$2.4350-Day Range$2.35▼$3.1452-Week Range$1.10▼$12.42Volume85 shsAverage Volume1.23 million shsMarket Capitalization$253.58 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Zymergen alerts: Email Address Ad American Hartford Gold GroupPrepare for a Recession Unlike Any OtherDave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dave Ramsey made a stunning miscalculation while live on air: “Am I worried about this? Absolutely not.” Frankly, I've never seen someone so confident in being wrong… Because what’s happening to the US Dollar is not something you should “keep an eye on”… But instead, is an imminent threat you should get ahead of right NOW.GET THE FREE GUIDE About Zymergen Stock (NASDAQ:ZY)Zymergen Inc. design, develop, and commercialize microbes, molecules, and materials. It offers an automation solution comprising reconfigurable automation carts, a modular hardware building blocks that allow for assembly of work cells customized for the particular needs of a lab; and automation control software, a cloud-based software used to control integrated automation systems. It serves electronics, packaging, healthcare, agriculture, and other industries. Zymergen Inc. was incorporated in 2013 and is based in Emeryville, California. As of October 19, 2022, Zymergen Inc. operates as a subsidiary of Ginkgo Bioworks Holdings, Inc.Read More Ad American Hartford Gold GroupPrepare for a Recession Unlike Any OtherDave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dave Ramsey made a stunning miscalculation while live on air: “Am I worried about this? Absolutely not.” Frankly, I've never seen someone so confident in being wrong… Because what’s happening to the US Dollar is not something you should “keep an eye on”… But instead, is an imminent threat you should get ahead of right NOW.GET THE FREE GUIDE ZY Stock News HeadlinesSeptember 13 at 4:28 PM | msn.comSEC Charges Zymergen Inc. With Misleading IPO Investors About Company’s Market Potential and Sales ProspectsAugust 27, 2024 | sg.finance.yahoo.comOhmium Announces Enakshi Singh as New Chief Financial OfficerSeptember 16, 2024 | Paradigm Press (Ad)Kamala’s Dirty Election Move… RevealedAccording to former advisor to the CIA, the Pentagon and the White House Jim Rickards… Kamala and her puppet masters are planning this dirty election move… August 9, 2024 | seekingalpha.comGinkgo Bioworks Holdings, Inc. (DNA) Q2 2024 Earnings Call TranscriptMay 10, 2024 | seekingalpha.comGinkgo Bioworks: Broken NarrativeMay 7, 2024 | finance.yahoo.comSynthetic Biology Market To Reach USD 57.1 Billion By 2032, Report By DataHorizzon ResearchApril 10, 2024 | finance.yahoo.comMethod Communications Introduces New Leadership Structure to Accelerate MomentumMarch 21, 2024 | tmcnet.comMolecular Robotics Market Share Analysis, Industry Trends & Statistics and 10 Year Growth Forecasts 2019-2029September 16, 2024 | Paradigm Press (Ad)Kamala’s Dirty Election Move… RevealedAccording to former advisor to the CIA, the Pentagon and the White House Jim Rickards… Kamala and her puppet masters are planning this dirty election move… March 13, 2024 | msn.comGM Appoints Former Tesla and Google Executive to Succeed Retiring Head of ManufacturingMarch 13, 2024 | marketwatch.comGM Taps Former Tesla Gigafactory Head To Lead ManufacturingMarch 1, 2024 | finance.yahoo.comQ4 2023 Ginkgo Bioworks Holdings Inc Earnings CallFebruary 13, 2024 | finance.yahoo.comMATTERWORKS ANNOUNCES BOARD UPDATESJanuary 19, 2024 | bizjournals.comSmartLabs gets $48M investment; CEO says 'we’re not done'January 11, 2024 | finance.yahoo.comSmartLabs Announces Biopharma Veteran Brian Taylor as New Interim CEONovember 8, 2023 | finance.yahoo.comGinkgo Bioworks Holdings Inc (DNA) Reports Q3 2023 Financial ResultsNovember 8, 2023 | msn.comTech and biotech firms slash hundreds of Bay Area jobs as layoffs widenNovember 7, 2023 | msn.comGinkgo Bioworks Holdings Q3 2023 Earnings PreviewSee More Headlines Receive ZY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Zymergen and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today9/16/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorBasic Materials Industry Commercial physical research Sub-IndustryN/A Current SymbolNASDAQ:ZY CUSIPN/A CIK1645842 Webwww.zymergen.com Phone415-801-8073FaxN/AEmployees502Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($3.55) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-361,790,000.00 Net Margins-2,508.94% Pretax Margin-2,508.42% Return on Equity-93.37% Return on Assets-61.14% Debt Debt-to-Equity RatioN/A Current Ratio4.59 Quick Ratio4.47 Sales & Book Value Annual Sales$16.74 million Price / Sales15.15 Cash FlowN/A Price / Cash FlowN/A Book Value$3.99 per share Price / Book0.61Miscellaneous Outstanding Shares104,355,000Free Float92,145,000Market Cap$253.58 million OptionableNot Optionable Beta1.69 Reduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.Get This Free Report Key ExecutivesMs. Enakshi Singh (Age 44)Chief Financial Officer Comp: $390.3kMr. Dmitriy RyaboyChief Technology OfficerMike DulinDirector of CommunicationsMr. Lincoln GermainChief Commercial OfficerMr. Subodh S. DeshmukhChief Devel. OfficerMr. Devin ScannellSr. VP of Drug DiscoveryMr. Duane Valz J.D.Sec.Ms. Mina Kim (Age 48)Corp. Sec. More ExecutivesKey CompetitorsNational ResearchNASDAQ:NRCOmniAbNASDAQ:OABIAbsciNASDAQ:ABSIMaxCyteNASDAQ:MXCTLuna InnovationsNASDAQ:LUNAView All Competitors ZY Stock Analysis - Frequently Asked Questions When did Zymergen IPO? Zymergen (ZY) raised $401 million in an initial public offering on Thursday, April 22nd 2021. The company issued 13,600,000 shares at $28.00-$31.00 per share. J.P. Morgan, Goldman Sachs, BofA Securities, Cowen, UBS Investment Bank and Lazard served as the underwriters for the IPO. This page (NASDAQ:ZY) was last updated on 9/16/2024 by MarketBeat.com Staff From Our PartnersMore Than 30 Federal Agencies Buy From This Cybersecurity TechIn January of 2022 Ukraine was hit by an especially nasty piece of malware, named WhisperGate. By then Ukra...Capital Trends | SponsoredBiden's Executive Order, Dems Digital Money Legislation, First Step ToDonald Trump once again sounded the alarm against Fed-controlled digital currencies (CBDCs). If these plans...Monetary Gold | Sponsored44-year Wall Street Vet: “Permanent devastation is coming to America”After 44 years on Wall Street, I've seen it all... Black Monday, the Great Recession, the Covid crash. B...InvestorPlace | SponsoredBREAKING NEWS: AI Tech Now Used to Stop School ShootersTwo seconds. That's all it takes for Knightscope's Automated Gunshot Detection to notify authorities and map a...Market JAR | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredPrepare for a Recession Unlike Any OtherDave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dav...American Hartford Gold Group | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredNvidia needs these 3 companies on a new $1 trillion SuperprojectNvidia is pivoting to a new $1 trillion Superproject that could revolutionize the AI industry… again. And i...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zymergen Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Zymergen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.